Phx-3 (2-Aminophenoxazine-3-one) is highly selective for NHE1 inhibition and was shown to selectively stimulate apoptosis in a variety of cancer cell lines while normal lymphocytes were not affected [19,234]. Here, SLC9A1 is linked to cancer.